November 2009 Issue of MMM
After last year's MM&M Awards produced success stories for numerous "nimble, smaller" shops, it was interesting to see some of the big boys fighting back ...
How Millennium: The Takeda Oncology Company, Pfizer and others are turning to the web to better train sales reps and get more "face" time with ...
When your patient population is just 10,000, the pharma marketing rulebook goes out of the window. Ben Comer examines one of the most successful ultra ...
With FDA set to hold its first public hearings on Internet promotion in 13 years, Matthew Arnold looks at the key questions and what might ...
Scott Hensley is a little like digital health journalism's Johnny Appleseed. Having served as the founding editor of the Wall Street Journal Health Blog, Hensley ...
I've heard people say that the questions in this business never change; only the answers change. I might have bought this as a point of ...
Readers of this column are not surprised at the firestorm of vaccine mongering--entirely unsubstantiated and inflammatory, that has been leveled at the new swine flu ...
Last month, FDA issued its Strategic Plan for Risk Communication, a 44-page tome 10 years in the making by multiple agency and external committees.
The US Department of Labor (DOL) filed an amicus brief with a federal appeals court in support of Novartis sales reps fighting for overtime compensation.
Cegedim Dendrite released its flagship Customer Relationship Management (CRM) suite, Mobile Intelligence, for BlackBerry smartphone users.
Featuring news about Access Pharma, iMedicor, MuGard, Ariad Healthcare, EMD Serono and Aptilon
Med Ed Report
GlaxoSmithKline is cutting off commercial CME providers, following Pfizer's lead.
The ACCME submitted additional testimony to the Senate Special Committee on Aging, pushing back against the notions that the boundary between promotion and education in ...
Featuring news about The New England Journal of Medicine, the American Academy of Orthopaedic Surgeons, Merck, Schering-Plough, Wyeth and Agency DesignWrite
Sage announced plans to launch a new bimonthly journal in February 2010, titled the Journal of Asthma & Allergy Educators (JAAE).
Serviance Media launched a new social network - TheMedicalStop.com - for all members of the healthcare community, from EMTs and hospital administrators to physicians, sales ...
Featuring news about Oakstone Medical, RadiologyDaily.com, Cold Spring Publishing, The Journal of Advanced Practitioner in Oncology and MedPage Today
With the proliferation of tablet PCs and off-site interactions, are sales reps able to engender the same kind of personal touch with doctors that both ...
MSN announced the launch of My Health Info, a new site for consumers that incorporates Microsoft's HealthVault profiles into a comprehensive offering that includes tools ...
Everyday Health launched a tool allowing patients to query a video doctor by entering a symptom, and then responding to follow-up questions.
Cook Medical launched a third site for physicians and consumers, this time focusing on a suite of tissue repair products.
Featuring news about Quintiles, ClinicalResearch.com, Merck, The Merck Manual, Google Health and MDLiveCare
Abbott Laboratories has achieved something quite rare with the latest DTC print campaign for Humira, its rheumatoid athritis (RA) drug.
November is Diabetes Awareness Month and manufacturers in the space, including Boehringer Ingelheim and Novo Nordisk, are observing it with educational campaigns.
Pfizer has given McCann HumanCare the heave-ho on its Viagra consumer account, awarding the business to McGarryBowen following a review.
Wyeth enlisted actress and artist Jane Seymour for an unbranded rheumatoid arthritis (RA) campaign in Europe.
The FDA's 14 letters warning companies about sponsored links on search engines all but eliminated industry use of the media, according to ComScore.
Featuring news about the American College of Physicians, FDA, Proctor & Gamble, Tampax, Myriad Genetics and the BRACAnalysis test
Sermo is offering clients on-demand physician focus groups.
MDLinx, a division of M3 USA, had its physician panel verified by the Marketing Research Association (MRA), a process that involved a review of MDLinx's ...
The WeissComm Group (WCG) hired European blogger and podcaster Neville Hobson to head social media activities in Europe, and also added new digital-focused employees in ...
Interpublic Group (IPG) aligned its Deutsch and Lowe Worldwide agencies in North America. Deutsch will now oversee and manage Lowe's US offices, including Lowe Health.
Featuring news about Baer Consulting, RxED, Porter Novelli, Loomis Group Health, Capella Advisors and CommonHealth
By getting back to basics, the FDA's new leadership says its first priority is to restore public confidence in an agency whose public esteem has ...
Less than three weeks after FDA commissioner Margaret Hamburg pledged better enforcement against firms violating agency laws and regulations, swifter and more aggressive actions by ...
The FDA says it is developing a qualitative framework for benefit/risk analysis out of recent case studies that suggested five key considerations a regulator must ...
Venue-based medical speaker events, such as dinner meetings, are experiencing a sharp decline after decades of steady growth.
Mr. Ross, when you headed KPR Informedia, did you submit articles to medical journals that were ghostwritten?
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.